Clinical Trial Update: Phase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector [Phase 1]

View source ↗

Summary

A Phase I trial assessed intramuscular midazolam delivered via an autoinjector for seizures; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seizures

Drugs mentioned

• Midazolam (Midazolam)

Snippet

Sponsor: U.S. Army Office of the Surgeon General | Conditions: Seizures | Phase 1 | Status: COMPLETED